TheraCell

Northridge, United States Founded: 2008 • Age: 18 yrs Acquired By ISTO Biologics
Allograft solutions for spinal surgery are provided by TheraCell.

About TheraCell

TheraCell is a company based in Northridge (United States) founded in 2008 was acquired by ISTO Biologics in April 2022.. TheraCell has raised $1.42 million across 2 funding rounds from investors including ISTO Biologics. TheraCell operates in a competitive market with competitors including Horizon Therapeutics, Imbed Biosciences, Osteal Therapeutics, Cresilon and Kane Biotech, among others.

  • Headquarter Northridge, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Theracell, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Veterinary & Animal Health
Healthcare → Medical Devices & Diagnostics
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.42 M (USD)

    in 2 rounds

  • Latest Funding Round
    $75 K (USD), Seed

    Mar 16, 2015

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    ISTO Biologics

    (Apr 05, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of TheraCell

TheraCell has successfully raised a total of $1.42M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $75 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $75,000
  • First Round

    (01 Oct 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2015 Amount Seed - TheraCell Valuation

investors

Oct, 2010 Amount Seed - TheraCell Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in TheraCell

TheraCell has secured backing from 1 investor. Prominent investors backing the company include ISTO Biologics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Developer of treatments for cartilage and bone problems
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by TheraCell

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - TheraCell

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Theracell Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of TheraCell

TheraCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Imbed Biosciences, Osteal Therapeutics, Cresilon and Kane Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of drugs for treating rare and autoimmune diseases
domain founded_year HQ Location
Nanotech-based wound care products are developed and provided.
domain founded_year HQ Location
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
domain founded_year HQ Location
Developer of hemostatic products for wound care
domain founded_year HQ Location
Therapeutic solutions for biofilm prevention and removal are developed.
domain founded_year HQ Location
Small molecule therapeutics for bone regeneration are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about TheraCell

When was TheraCell founded?

TheraCell was founded in 2008 and raised its 1st funding round 2 years after it was founded.

Where is TheraCell located?

TheraCell is headquartered in Northridge, United States. It is registered at Northridge, California, United States.

Is TheraCell a funded company?

TheraCell is a funded company, having raised a total of $1.42M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.34M, raised on Oct 01, 2010.

What does TheraCell do?

TheraCell was founded in 2008 and is based in Northridge, United States. Allograft solutions tailored for spinal surgery procedures are offered by the company. Specific products include the TheraFuze DBF Fiber Wrap, Fiber Anchor, and Fiber Bag. Operations focus on the medical device sector, with emphasis on procedure-specific innovations for orthopedic applications in spinal care.

Who are the top competitors of TheraCell?

TheraCell's top competitors include Imbed Biosciences, Horizon Therapeutics and Cresilon.

Who are TheraCell's investors?

TheraCell has 1 investor. Key investors include ISTO Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available